MYND LIFE SCIENCES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.035 CAD | +16.67% |
|
+16.67% | -12.50% |
| Sales 2022 | - | Sales 2023 | - | Capitalization | 717K 984K 59.83M |
|---|---|---|---|---|---|
| Net income 2022 | -3M -4.11M -250M | Net income 2023 | -1M -1.37M -83.42M | EV / Sales 2022 | - |
| Net Debt 2022 | 2.59 3.55 215.71 | Net Debt 2023 | 3 4.11 250.24 | EV / Sales 2023 | - |
| P/E ratio 2022 |
-1.05
x | P/E ratio 2023 |
-0.47
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 40.17% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +16.67% | ||
| Current month | +16.67% | ||
| 1 month | +75.00% | ||
| 3 months | +40.00% | ||
| 6 months | +250.00% | ||
| Current year | -12.50% |
1 month
0.02
0.04
Current year
0.010.04
1 year
0.010.10
3 years
0.012.50
5 years
0.012.50
10 years
0.012.50
| Managers | Title | Age | Since |
|---|---|---|---|
John Campbell
CEO | Chief Executive Officer | 53 | 26/20/26 |
Lyle Oberg
FOU | Founder | 63 | 06/18/06 |
| Founder | 65 | 06/18/06 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Founder | 65 | 06/18/06 | |
Lyle Oberg
FOU | Founder | 63 | 06/18/06 |
John Campbell
CEO | Chief Executive Officer | 53 | 26/20/26 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/24/30 | 0.035 | +16.67% | 1,000 |
Delayed Quote Canadian Securities Exchange, April 01, 2024 at 12:39 am IST
More quotes
MYND Life Sciences Inc. is a Canada-based medical biotech drug research and development company. The Company is focused on neuro-pharmaceutical drug development, diagnostics and vaccines. It is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio) pharmaceutical companies by molecular concepts for the applications of psilocybin analogs for overcoming disease. The Company advances pharmaceutical developments through rigorous science and clinical trials while diligently patenting and safeguarding its intellectual property. The Company is engaged in collaborative research with the Michael Smith Laboratories at the University of British Columbia.
Calendar
06/06/2024
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -12.50% | 1.22M | |
| -1.17% | 104B | |
| +2.87% | 97.47B | |
| +5.01% | 22.25B | |
| -14.77% | 21.68B | |
| -8.63% | 18.2B | |
| -39.98% | 17.02B | |
| -13.21% | 16.36B | |
| +8.55% | 14.39B | |
| +35.75% | 12.37B |
- Stock Market
- Equities
- MYND Stock
